1984-1986: Teaching assistant: (Biostatistics and programming course post graduate studies, Simulations of biological systems Course final year, B.Sc studies). Bar-Ilan University, Ramat Gan, Israel.

1986-1990: Research assistance. Bar-Ilan University, Ramat Gan, Israel.

2000-  : The Israel Society for Prevention of Heart Attacks, Research Coordinating CenterNeufeld Cardiac Research Institute, Tel-Hashomer, Israel. EpidemiologistHead of Data Management and the computer Unit


B.Sc. - 1984: Biology / Department of Life Sciences - Bar Ilan University
M.Sc - 1986: Biology / Department of Life Sciences - Bar Ilan University
PhD student: Epidemiology / Sackler School of Medicine - Tel-Aviv university
Subject: Morbidity, Mortality and their Determinants among Women with Coronary Heart Disease.



Cardiovascular Epidemiology
Controlled multicenter Clinical
Quality assurance of clinical data




Barasch E, Benderly M, Graff E, Behar S, Reicher- Reiss H, Caspi A, Pelled B, Reisin L, Roguin N, Goldbourt U and the Principal Investigators of the Bezafibrate Infarction Prevention Study Group. Plasma Fibrinogen Levels and Their Correlates in 5400 Coronary Heart Disease Patients. The Bezafibrate Infarction Prevention (BIP) Study.
J Clin Epidemiol, 1995; 48(6): 757-765.

Benderly M, Graff E, Reicher-Reiss H, Behar S, Brunner D, and Goldbourt U, for the Bezafibrate Infarction Prevention (BIP) Study Group. Fibrinogen is a predictor of mortality in coronary heart disease patients.
Arterioscler Thromb Vasc biol 1996; 16:351-356.

Benderly M, Behar S, Reicher-Reiss H, Boyko V, Goldbourt U, for the SPRINT Study Group. Long Term Prognosis of Women after Myocardial Infarction.
Am J Epidemiol 1997; 146:153-160.

Haim M, Benderly M, Brunner D, Behar S, Graff E, Reicher-Reiss H, Goldbrourt U, for the BIP Study group. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) registry.
Circulation 1999;100:475-482.

Tanne D, Benderly M, Goldbourt U, Boyko V, Brunner D, Graff E, Reicher-Reiss H, Shotan A, Mandelzweig L, Behar S, and the Bezafibrate Infarction Prevention Study Group. A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the Bezafibrate Infarction Prevention Study.
Am J Med. 2001; 111:457-463.